Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Raluca Verona

11PUBLICATIONS

46CO-AUTHORS

Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Sep 22, 2025

Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study.

Ajai Chari, Niels W C J van de Donk, Bhagirathbhai Dholaria

|Aug 27, 2025

Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1.

Carolina Schinke, Paula Rodriguez-Otero, Niels W C J van de Donk

|Feb 26, 2025

Mechanisms of Response and Resistance to PSMA×CD3 Bispecifics in CD34+ Humanized Mice.

Bethany K Mattson Cypert, Krista Menard, Gerald Chu

|Aug 22, 2024

Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies.

Cyrille Touzeau, Amrita Y Krishnan, Philippe Moreau

|Apr 30, 2024

T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma.

Christie P M Verkleij, Chloe A O'Neill, Marloes E C Broekmans

|Apr 24, 2024

Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study.

Diana Cortes-Selva, Tatiana Perova, Sheri Skerget

Pageof 2

Frequent Collaborators

3 joint publications

Nizar J Bahlis

2 joint publications

Maria-Victoria Mateos

2 joint publications

Sonja Zweegman

2 joint publications

Shun Xin Wang Lin

2 joint publications

Christie P M Verkleij

2 joint publications

Paula Rodriguez-Otero

1 joint publications

Alfredo Perales-Puchalt

1 joint publications

Bronno van der Holt

1 joint publications

Chloe A O'Neill

1 joint publications

Marloes E C Broekmans

Frequent Collaborators

3 joint publications

Nizar J Bahlis

2 joint publications

Maria-Victoria Mateos

2 joint publications

Sonja Zweegman

2 joint publications

Shun Xin Wang Lin

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on : Dec 13, 2018

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on : Dec 16, 2022

See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube (SWCNT)-delivered MALAT1 Antisense Oligos

Published on : Dec 13, 2018

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on : Dec 16, 2022

See more related videos